View in EDS

Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.

Saved in:
Bibliographic Details
Title: Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Authors: Bordry N; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Addeo A; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Jaksic C; CRC& Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and Geneva University Hospital, Geneva, Switzerland., Dutoit V; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Roux-Lombard P; Immunology and Allergology Laboratory, Geneva University Hospital, University of Geneva, 1205 Geneva, Switzerland., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Shah PK; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Gayet-Ageron A; CRC& Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and Geneva University Hospital, Geneva, Switzerland., Friedlaender A; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.; Oncology Department, University Hospital of Geneva, Switzerland, Clinique Générale Beaulieu, Geneva, Switzerland., Bugeia S; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Gutknecht G; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Battagin A; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Di Marco M; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Simand PF; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Labidi-Galy I; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Fertani S; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Sandoval J; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Dietrich PY; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland., Mach N; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.
Source: IScience [iScience] 2021 Dec 24; Vol. 25 (1), pp. 103699. Date of Electronic Publication: 2021 Dec 24 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34977496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bordry+N%22">Bordry N</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Addeo+A%22">Addeo A</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jaksic+C%22">Jaksic C</searchLink>; CRC& Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dutoit+V%22">Dutoit V</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Roux-Lombard+P%22">Roux-Lombard P</searchLink>; Immunology and Allergology Laboratory, Geneva University Hospital, University of Geneva, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shah+DP%22">Shah DP</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shah+PK%22">Shah PK</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gayet-Ageron+A%22">Gayet-Ageron A</searchLink>; CRC& Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Friedlaender+A%22">Friedlaender A</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.; Oncology Department, University Hospital of Geneva, Switzerland, Clinique Générale Beaulieu, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bugeia+S%22">Bugeia S</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gutknecht+G%22">Gutknecht G</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Battagin+A%22">Battagin A</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Di+Marco+M%22">Di Marco M</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Simand+PF%22">Simand PF</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fertani+S%22">Fertani S</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sandoval+J%22">Sandoval J</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dietrich+PY%22">Dietrich PY</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mach+N%22">Mach N</searchLink>; Department of Oncology, Geneva University Hospital, University of Geneva and Swiss Cancer Center Leman, Rue Perret-Gentil 4, 1205 Geneva, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2021 Dec 24; Vol. 25 (1), pp. 103699. <i>Date of Electronic Publication: </i>2021 Dec 24 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34977496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.isci.2021.103699
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103699
    Titles:
      – TitleFull: Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bordry N
      – PersonEntity:
          Name:
            NameFull: Addeo A
      – PersonEntity:
          Name:
            NameFull: Jaksic C
      – PersonEntity:
          Name:
            NameFull: Dutoit V
      – PersonEntity:
          Name:
            NameFull: Roux-Lombard P
      – PersonEntity:
          Name:
            NameFull: Shah DP
      – PersonEntity:
          Name:
            NameFull: Shah PK
      – PersonEntity:
          Name:
            NameFull: Gayet-Ageron A
      – PersonEntity:
          Name:
            NameFull: Friedlaender A
      – PersonEntity:
          Name:
            NameFull: Bugeia S
      – PersonEntity:
          Name:
            NameFull: Gutknecht G
      – PersonEntity:
          Name:
            NameFull: Battagin A
      – PersonEntity:
          Name:
            NameFull: Di Marco M
      – PersonEntity:
          Name:
            NameFull: Simand PF
      – PersonEntity:
          Name:
            NameFull: Labidi-Galy I
      – PersonEntity:
          Name:
            NameFull: Fertani S
      – PersonEntity:
          Name:
            NameFull: Sandoval J
      – PersonEntity:
          Name:
            NameFull: Dietrich PY
      – PersonEntity:
          Name:
            NameFull: Mach N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 12
              Text: 2021 Dec 24
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2589-0042
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: IScience
              Type: main
ResultId 1